KRTAP2-1 inhibitors refer to a class of chemical compounds that are designed to interfere with the function of the keratin-associated protein 2-1 (KRTAP2-1), a member of the keratin-associated protein family. KRTAPs are integral in the structure of hair and wool fibers, where they form part of the matrix that surrounds the keratin filaments, contributing to the rigidity and resilience of these fibrous proteins. KRTAP2-1, in particular, is involved in the cross-linking of keratin filaments through disulfide bond formation, a process that stabilizes the overall structure of keratinized tissues. Inhibitors of KRTAP2-1 target this protein to modulate the biochemical properties of keratin filaments, affecting their assembly and interactions within the extracellular matrix of keratinized cells.
The chemical nature of KRTAP2-1 inhibitors is typically characterized by their ability to bind to the active or interaction sites of the KRTAP2-1 protein. These inhibitors may disrupt disulfide bond formation or interfere with other protein-protein interactions within the keratin structure. They could function by directly interacting with the protein or by altering post-translational modifications that regulate KRTAP2-1's activity. Structurally, these inhibitors often possess moieties that can interact with cysteine residues, which are critical for disulfide bond formation. By altering the structural dynamics of KRTAP2-1, these inhibitors provide valuable tools for studying the molecular mechanics of keratinization and protein assembly in fibrous tissues. Understanding how these compounds affect KRTAP2-1 provides insight into the molecular regulation of keratin-associated processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits protein synthesis, potentially decreasing KRTAP2-1 production. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Inhibits proteasomal degradation, potentially affecting KRTAP2-1 protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Binds to DNA and inhibits RNA synthesis, possibly reducing KRTAP2-1 transcription. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Causes premature chain termination during protein synthesis, possibly leading to reduced KRTAP2-1 levels. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Inhibits lysosomal function, potentially affecting KRTAP2-1 turnover. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR and can decrease overall protein synthesis, potentially lowering KRTAP2-1 levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, potentially increasing KRTAP2-1 levels due to reduced degradation. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Inhibits RNA polymerase II, potentially decreasing KRTAP2-1 mRNA synthesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Inhibits histone deacetylase, potentially affecting KRTAP2-1 gene expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Binds to Hsp90 affecting its client proteins' folding and function, including potentially KRTAP2-1. | ||||||